29 Apr 2013, BioSpectrum Bureau , BioSpectrum
Singapore: BD Diagnostics has collaborated with Bruker Daltonics to sell and distribute front-line technical support for the co-labeled BD Bruker Maldi Biotyper System.
Microbial identification and antimicrobial susceptibility testing is the end-point of majority of work that a microbiology lab performs on a daily basis and is very time consuming. The BD Bruker Maldi Biotyper System, combined with automated antimicrobial susceptibility testing on the BD Phoenix Microbiology System and the BD EpiCenter Microbiology Data Management System, will facilitate a fully integrated and optimized approach for laboratory workflow.
"BD believes mass spectrometry technologies are the future of microbial identification," said Mr Jamie Condie, VP and GM, Diagnostic Systems, Infectious Disease, BD. "Combining Bruker's expertise in this area with our advanced lab automation experience, the BD Bruker Maldi Biotyper System will enhance our customers' clinical decision making and laboratory workflow."
Antimicrobial susceptibility testing is conducted via traditional automated systems such as the BD Phoenix System. The combination of the BD Phoenix System and the Bruker Maldi Biotyper, and data management through the BD EpiCenter System, will provide laboratorians with a new approach to identification and susceptibility testing.
This is expected to reduce the turnaround time for critical diagnostic results while also improving laboratory efficiency and costs. Identification of pathogens will occur in minutes as compared to hours, thus directly impacting patient management.